Compugen (CGEN) Total Non-Current Liabilities (2009 - 2026)

Compugen's (CGEN) quarterly Total Non-Current Liabilities came in at $28.5 million in Q1 2026, down 23.76% year-on-year from $37.3 million in Q1 2025, and down 8.95% quarter-over-quarter from $31.3 million in Q4 2025.

Compugen (CGEN) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Compugen has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $28.5 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $28.5 million, down 23.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.5 million (down 23.76% YoY), and the FY2025 annual result was $31.3 million, down 21.67% from the prior year.
  • Total Non-Current Liabilities came in at $28.5 million for Q1 2026 at Compugen, down from $31.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $39.9 million in Q4 2024 to a low of $4.0 million in Q3 2023.
  • The 5-year median for Total Non-Current Liabilities is $28.5 million (2026), against an average of $21.3 million.
  • Across the five-year window, Total Non-Current Liabilities tumbled 45.34% in 2022 and surged 779.92% in 2024, its largest moves.
  • Compugen's Total Non-Current Liabilities stood at $4.6 million in 2022, then jumped by 544.72% to $29.5 million in 2023, then soared by 35.28% to $39.9 million in 2024, then decreased by 21.67% to $31.3 million in 2025, then retreated by 8.95% to $28.5 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $28.5 million (Q1 2026), $31.3 million (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 28.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.47 Mn
Dec 31, 2025 31.27 Mn
Sep 30, 2025 33.74 Mn
Jun 30, 2025 35.69 Mn
Mar 31, 2025 37.34 Mn
Dec 31, 2024 39.92 Mn
Sep 30, 2024 35.27 Mn
Jun 30, 2024 27.06 Mn
Mar 31, 2024 29.40 Mn
Dec 31, 2023 29.51 Mn
Sep 30, 2023 4.01 Mn
Jun 30, 2023 4.25 Mn
Mar 31, 2023 4.39 Mn
Dec 31, 2022 4.58 Mn
Sep 30, 2022 4.78 Mn
Jun 30, 2022 5.94 Mn
Mar 31, 2022 7.08 Mn
Dec 31, 2021 8.37 Mn
Sep 30, 2021 7.22 Mn
Jun 30, 2021 7.55 Mn